Rachel Williamson

3.1k total citations · 1 hit paper
41 papers, 2.5k citations indexed

About

Rachel Williamson is a scholar working on Epidemiology, Organic Chemistry and Surgery. According to data from OpenAlex, Rachel Williamson has authored 41 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Organic Chemistry and 7 papers in Surgery. Recurrent topics in Rachel Williamson's work include Liver Disease Diagnosis and Treatment (12 papers), Pancreatitis Pathology and Treatment (6 papers) and Liver Disease and Transplantation (5 papers). Rachel Williamson is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Pancreatitis Pathology and Treatment (6 papers) and Liver Disease and Transplantation (5 papers). Rachel Williamson collaborates with scholars based in Australia, United Kingdom and United States. Rachel Williamson's co-authors include Jackie F. Price, Mark W. J. Strachan, Alan Riboldi‐Tunnicliffe, Jason R. Price∥, Daniel J. Ericsson, Santosh Panjikar, M Clift, Christine L. Gee, David Aragão and Nathan Cowieson and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Chemistry of Materials.

In The Last Decade

Rachel Williamson

40 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A molecular nematic liquid crystalline material for high-performance organic photovoltaics

2015 580 citations Kuan Sun, Zeyun Xiao et al. Nature Communications profile →

Peers

Countries citing papers authored by Rachel Williamson

Since Specialization

Citations

This map shows the geographic impact of Rachel Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Williamson more than expected).

Fields of papers citing papers by Rachel Williamson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Williamson. The network helps show where Rachel Williamson may publish in the future.

Co-authorship network of co-authors of Rachel Williamson

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Williamson. A scholar is included among the top collaborators of Rachel Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Williamson. Rachel Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Putting the squeeze on valence tautomerism in cobalt-dioxolene complexes 2024 ·Nature Communications ·(unknown), (unknown), Gemma F. Turner, Moya A. Hay, Alan Riboldi‐Tunnicliffe, Rachel Williamson, Stephanie A. Boer, Lars Goerigk, Colette Boskovic, Stephen A. Moggach	7
2	Addition of hyaluronic acid to the FIB‐4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study 2021 ·Obesity Science & Practice ·(unknown), Stela McLachlan, Jonathan Fallowfield, Peter Hayes, Indra Neil Guha, Joanne R Morling, Stephen Glancy, Rachel Williamson, Rebecca M. Reynolds, Brian M. Frier, Nicola N. Zammitt, Jackie F. Price, Mark W. J. Strachan	5
3	Non‐invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study 2020 ·Liver International ·(unknown), Stela McLachlan, Jonathan Fallowfield, Patrick K. A. Kearns, Peter Hayes, Indra Neil Guha, Joanne R Morling, Stephen Glancy, Rachel Williamson, Rebecca M. Reynolds, Brian M. Frier, Nicola N. Zammitt, Jackie F. Price, Mark W. J. Strachan	13
4	Crystal structure of posnjakite formed in the first crystal water-cooling line of the ANSTO Melbourne Australian Synchrotron MX1 Double Crystal Monochromator 2020 ·Acta Crystallographica Section E Crystallographic Communications ·Stuart J. Mills, Jun Aishima, David Aragão, Tom T. Caradoc-Davies, Nathan Cowieson, Christine L. Gee, Daniel J. Ericsson, S.J. Harrop, Santosh Panjikar, K.M. Smith, Alan Riboldi‐Tunnicliffe, Rachel Williamson, Jason R. Price∥	1
5	MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron 2018 ·Journal of Synchrotron Radiation ·David Aragão, Jun Aishima, (unknown), (unknown), M Clift, Nathan Cowieson, Daniel J. Ericsson, Christine L. Gee, Sofia Macedo, (unknown), Santosh Panjikar, Jason R. Price∥, Alan Riboldi‐Tunnicliffe, (unknown), Rachel Williamson, (unknown)	359
6	A molecular nematic liquid crystalline material for high-performance organic photovoltaics breakdown → 2015 ·Nature Communications ·Kuan Sun, Zeyun Xiao, Shirong Lu, Wojciech Zajączkowski, Wojciech Pisula, Eric Hanssen, Jonathan M. White, Rachel Williamson, Jegadesan Subbiah, Jianyong Ouyang, Andrew B. Holmes, Wallace W. H. Wong, David J. Jones	580
7	γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study 2015 ·Diabetologia ·Joanne R Morling, Jonathan Fallowfield, Rachel Williamson, C. Robertson, Stephen Glancy, Indra Neil Guha, Mark W. J. Strachan, Jackie F. Price	13
8	Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study 2015 ·QJM ·Joanne R Morling, Jonathan Fallowfield, Indra Neil Guha, Rachel Williamson, Mohammed Ali, Stephen Glancy, Mark W. J. Strachan, Jackie F. Price	8
9	MX1: a bending-magnet crystallography beamline serving both chemical and macromolecular crystallography communities at the Australian Synchrotron 2014 ·Journal of Synchrotron Radiation ·Nathan Cowieson, David Aragão, M Clift, Daniel J. Ericsson, Christine L. Gee, S.J. Harrop, (unknown), Santosh Panjikar, Jason R. Price∥, Alan Riboldi‐Tunnicliffe, Rachel Williamson, Tom T. Caradoc-Davies	342
10	Cell signalling and diabetes 2013 ·Diabetic Medicine ·Victor A. Gault, (unknown), (unknown), Christian Hölscher, Peter R. Flatt, Rachel Williamson, Ramzi Ajjan, Katharina Heß, Saad Alzahrani, Rebecca M. Reynolds, Jackie F. Price, (unknown)	1
11	Association between hepatic steatosis and non-alcoholic fatty liver disease and clot lysis dynamics in Type 2 diabetes: the Edinburgh Type 2 Diabetes Study (ET2DS) 2013 ·Diabetic Medicine ·Rachel Williamson, R. A. Ajjan, Katharina Heß, Saad Alzahrani, Rebecca M. Reynolds, Jackie F. Price, Mark W. J. Strachan	1
12	Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study 2012 ·European Journal of Endocrinology ·Rebecca M. Reynolds, Javier Labad, (unknown), Rachel Williamson, Mark W. J. Strachan, Ian J. Deary, Gordon Lowe, Jackie F. Price, Brian R. Walker, (unknown)	22
13	The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: Intra- and interobserver variability and comparison with magnetic resonance spectroscopy 2011 ·Clinical Radiology ·Rachel Williamson, Elisa Perry, Stephen Glancy, Ian Marshall, Calum Gray, Lisa D. Nee, Peter Hayes, Shareen Forbes, B M Frier, Geoffrey I. Johnston, Amanda Lee, Rebecca M. Reynolds, Jackie F. Price, Mark W. J. Strachan	30
14	Prevalence and markers of advanced liver disease in type 2 diabetes 2011 ·QJM ·Rachel Williamson, Jackie F. Price, Peter Hayes, Stephen Glancy, Brian M. Frier, Geoffrey I. Johnston, Rebecca M. Reynolds, Mark W. J. Strachan, (unknown)	30
15	First X‐ray Structure of a N‐Naphthaloyl‐Tethered Chiral Dirhodium(II) Complex: Structural Basis for Tether Substitution Improving Asymmetric Control in Olefin Cyclopropanation 2010 ·Chemistry - A European Journal ·Ashraf Ghanem, Michael G. Gardiner, Rachel Williamson, Paul Müller	74
16	Diaryl ether synthesis in supercritical carbon dioxide in batch and continuous flow modes 2008 ·Chemical Communications ·Jin‐Kyun Lee, Matthew J. Fuchter, Rachel Williamson, Gary A. Leeke, (unknown), Ian F. McConvey, Simon Saubern, John H. Ryan, Andrew B. Holmes	23
17	A Study of the Heck Reaction in Non-Polar Hydrocarbon Solvents and in Supercritical Carbon Dioxide 2007 ·Australian Journal of Chemistry ·Jin‐Kyun Lee, Rachel Williamson, Andrew B. Holmes, (unknown), Ian F. McConvey	2
18	Anoplocephala perfoliataof horses – significant scope for further research, improved diagnosis and control 2005 ·Parasitology ·Robin B. Gasser, Rachel Williamson, Ian Beveridge	122
19	Stereospecific deuteration of 2-deoxyerythrose 4-phosphate using 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase 2005 ·Bioorganic & Medicinal Chemistry Letters ·Rachel Williamson, (unknown), Geoffrey B. Jameson, Emily J. Parker	8
20	The distribution of Anoplocephala perfoliata in the intestine of the horse and associated pathological changes 1997 ·Veterinary Parasitology ·Rachel Williamson, Robin B. Gasser, Derek Middleton, Ian Beveridge	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact